Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KMS MedisurgiBOM:540468 79 Earnings Yield (Joel Greenblatt) % is 1.05% as of Mar. 2026, which is 48% below its 10-year median of 2.00. GuruFocus rates BOM:540468 with a GF Score™ of 79/100 and a GF Value™ of ₹111.52. The stock has 8 warning signs investors should review. Among 849 Medical Devices & Instruments companies, KMS Medisurgi ranks better than 50.41% on this metric.
KMS Medisurgi's Enterprise Value for the quarter that ended in Mar. 2026 was ₹414.1 Mil.
KMS Medisurgi's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ₹4.4 Mil. KMS Medisurgi's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2026 was 1.05%.
The historical rank and industry rank for KMS Medisurgi's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
BOM:540468'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: 1 Med: 2 Max: 4.62
Current: 1
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of KMS Medisurgi was 4.62%. The lowest was 1.00%. And the median was 2.00%.
BOM:540468's Earnings Yield (Joel Greenblatt) % is ranked better than 50.41% of 849
companies
in the Medical Devices & Instruments industry
Industry Median: 0.87
vs BOM:540468: 1.00
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. KMS Medisurgi's Forward Rate of Return (Yacktman) % for the quarter that ended in Mar. 2026 was 11.90%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
KMS Medisurgi Earnings Yield (Joel Greenblatt) % Related Terms
KMS Medisurgi Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for KMS Medisurgi's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, KMS Medisurgi's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KMS Medisurgi Earnings Yield (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, KMS Medisurgi's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where KMS Medisurgi's Earnings Yield (Joel Greenblatt) % falls into.
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
KMS Medisurgis Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Mar. 2026 is calculated as
For company reported semi-annually or annually, GuruFocus only calculate annual data for Earnings Yield (Joel Greenblatt) and apply the annual figure to corresponding quarter.
What does a Earnings Yield (Joel Greenblatt) % of 1.05% mean?
KMS Medisurgi (BOM:540468) has a Earnings Yield (Joel Greenblatt) % of 1.05% as of Mar. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on KMS Medisurgi and its competitors. This is 48% below median its historical median of 2.00. Over the past decade, KMS Medisurgi's Earnings Yield (Joel Greenblatt) % has ranged from 1.00 to 4.62. According to the industry distribution chart, KMS Medisurgi ranks #421 out of 849 companies in the Medical Devices & Instruments industry, placing it in the top 49.6%.
Is KMS Medisurgi's Earnings Yield (Joel Greenblatt) % too high?
KMS Medisurgi's current Earnings Yield (Joel Greenblatt) % of 1.05% is 48% below median its 10-year median of 2.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 4.62. The Medical Devices & Instruments industry median Earnings Yield (Joel Greenblatt) % is 0.87. KMS Medisurgi's value of 1.05% is 20.7% above this industry median. Based on the distribution chart, KMS Medisurgi ranks #421 out of 849 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, KMS Medisurgi has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does KMS Medisurgi's Earnings Yield (Joel Greenblatt) % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, KMS Medisurgi ranks #421 out of 849 companies for Earnings Yield (Joel Greenblatt) %. This puts KMS Medisurgi in the upper half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 0.87. KMS Medisurgi's value of 1.05% is 20.7% above this benchmark. Historically, KMS Medisurgi's own Earnings Yield (Joel Greenblatt) % has ranged from 1.00 to 4.62 over the past decade. While the company's 10-year median is 2.00 vs. the industry median of 0.87, KMS Medisurgi has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median Earnings Yield (Joel Greenblatt) % among Medical Devices & Instruments companies is 0.87, based on 849 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KMS Medisurgi's current Earnings Yield (Joel Greenblatt) % of 1.05% is 20.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on KMS Medisurgi and its competitors. For the Medical Devices & Instruments industry, the median Earnings Yield (Joel Greenblatt) % is 0.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KMS Medisurgi's current Earnings Yield (Joel Greenblatt) % is 1.05%, which is 48% below median its own 10-year median of 2.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KMS Medisurgi stock overvalued right now?
KMS Medisurgi (BOM:540468) has a current Earnings Yield (Joel Greenblatt) % of 1.05%. The stock's GF Value™ is ₹111.52, compared to a current price of ₹132.80 — trading 19.1% above its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is 1.05%, which is 48% below median its 10-year median of 2.00 and 20.7% above the Medical Devices & Instruments industry median of 0.87. KMS Medisurgi's overall GF Score™ is 79/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For KMS Medisurgi (BOM:540468), the current Earnings Yield (Joel Greenblatt) % is 1.05% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KMS Medisurgi (BOM:540468) Overvalued in 2026?
Based on GuruFocus' analysis, KMS Medisurgi stock appears to be overvalued.
The current stock price of ₹132.80 is trading 19.1% above its estimated GF Value™ of ₹111.52.
Key valuation signals for BOM:540468:
Earnings Yield (Joel Greenblatt) %: 1.05% (48% below median its 10-year median of 2.00)
GF Value™: ₹111.52 vs. price of ₹132.80 (19.1% above fair value)
Industry Position: 20.7% above the Medical Devices & Instruments median (#421 of 849)
No single metric tells the full story. See the BOM:540468 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KMS Medisurgi Ltd manufactures surgical tapes and dressings for hospitals, institutions, trade associations, exporters, and importers. The company manufactures and undertakes job work of various substartes like non-woven fabrics, PU films, cotton fabrics, and taffeta silk fabrics with adhesive. The company's international presence includes Vietnam, Dubai, Europe, Australia, Cambodia, India, Africa, Philippines, Russia, Pakistan, Bangladesh, and the USA. The company derives revenue from the sale of goods.
79GF Score
Get the complete analysis for BOM:540468
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:540468 has been successfully added to your 
